Physician profile
Sarah E Ray
NPI 1376838094
$9,170.88
in general payments reported to CMS, 2019-2025
30 companies · $1,655 in 2025
The $1,655 reported for 2025 was more than what 90% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,719 · 2022: $2,004 · 2023: $2,255 · 2024: $1,538 · 2025: $1,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,448.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,324.63 | 2021-2025 | |
| Pfizer INC. | $992.51 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $898.09 | 2021-2025 | Lifevest |
| Amgen INC. | $803.63 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $513.16 | 2022-2025 | Mitraclip, Jeti Peripheral Catheter, Jot Dx |
| Bayer Healthcare Pharmaceuticals INC. | $511.04 | 2021-2025 | |
| Cvrx, INC. | $463.85 | 2021-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $457.21 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $441.28 | 2021-2025 | Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.28 | 2021-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $377.01 | 2022-2024 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $373.17 | 2022-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $346.92 | 2022-2025 | Ozempic |
| Amarin Pharma, INC. | $212.98 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $162.18 | 2023-2025 | Verquvo |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $148.06 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $144.23 | 2022-2025 | Onpattro |
| Shockwave Medical, INC | $129.37 | 2025 | |
| Boston Scientific Corporation | $67.35 | 2021-2023 | Watchman Access System |
| Kiniksa Pharmaceuticals International, Plc | $60.85 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $58.27 | 2024 | |
| Irhythm Technologies, INC. | $35.75 | 2024 | Zio Xt Patch, Zio Monitor |
| Arbor Pharmaceuticals, INC. | $34.14 | 2021 | |
| Cardiva Medical, INC. | $34.07 | 2022 | |
| Sanofi-Aventis U.S. LLC | $33.82 | 2022-2024 | |
| Kowa Pharmaceuticals America, INC. | $33.72 | 2021-2022 | |
| Scpharmaceuticals INC. | $28.68 | 2024-2025 | |
| Glaxosmithkline, LLC. | $24.86 | 2025 | Shingrix, Arexvy |
| Inspire Medical Systems, INC. | $23.01 | 2025 | Inspire |
| Baxter Healthcare | $14.76 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.